Expression of gastrin-releasing peptide is increased by prolonged stretch of human myometrium, and antagonists of its receptor inhibit contractility

Journal of Physiology

Volumn 590, Issue 9, 2012, Pages 2081-2093

  Tattersall, Mark ^a   Cordeaux, Yolande ^a   Charnock Jones, D Stephen ^a   Smith, Gordon C S ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GASTRIN RELEASING PEPTIDE; OXYTOCIN; PD 176252; PEPTIDE HORMONE ANTAGONIST; POTASSIUM CHLORIDE; RC 3095; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; EXPLANT; FEMALE; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MUSCLE ISOMETRIC CONTRACTION; MYOMETRIUM; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; RNA TRANSCRIPTION; UTERINE STRETCH; UTERUS BIOPSY; UTERUS CONTRACTION; UTERUS FUNCTION; WESTERN BLOTTING;

BIOPSY; BLOTTING, WESTERN; BOMBESIN; FEMALE; GASTRIN-RELEASING PEPTIDE; GENE EXPRESSION PROFILING; HORMONE ANTAGONISTS; HUMANS; IMMUNOHISTOCHEMISTRY; INDOLES; MECHANOTRANSDUCTION, CELLULAR; MYOMETRIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXYTOCICS; OXYTOCIN; PEPTIDE FRAGMENTS; POTASSIUM CHLORIDE; PREGNANCY; PREMATURE BIRTH; RECEPTORS, BOMBESIN; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TISSUE CULTURE TECHNIQUES; UP-REGULATION; UTERINE CONTRACTION;

EID: 84860338928     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2012.228239     Document Type: Article

References (43)

1. Amiot F, Leiber D, Marc S & Harbon S (1993). GRP-preferring bombesin receptors increase generation of inositol phosphates and tension in rat myometrium. Am J Physiol Cell Physiol 265, C1579-1587.
2. Anastasi A, Erspamer V & Bucci M (1971). Isolation and structure of bombesin and alytesin, 2 analogous active peptides from the skin of the European amphibians Bombina and Alytes. Experientia 27, 166-167.
3. Arias F & Tomich P (1982). Etiology and outcome of low birth weight and preterm infants. Obstet Gynecol 60, 277-281.
4. Benya RV, Kusui T, Katsuno T, Tsuda T, Mantey SA, Battey JF & Jensen RT (2000). Glycosylation of the gastrin-releasing peptide receptor and its effect on expression, G protein coupling, and receptor modulatory processes. Mol Pharmacol 58, 1490-1501.
5. Caritis SN, Rouse DJ, Peaceman AM, Sciscione A, Momirova V, Spong CY et al (2009). Prevention of preterm birth in triplets using 17α-hydroxyprogesterone caproate: a randomized controlled trial. Obstet Gynecol 113, 285-292.
6. Carroll RE, Matkowskyj KA, Chakrabarti S, McDonald TJ & Benya RV (1999). Aberrant expression of gastrin-releasing peptide and its receptor by well-differentiated colon cancers in humans. Am J Physiol Gastrointest Liver Physiol 276, G655-665.
7. Challis JRG, Matthews SG, Gibb W & Lye SJ (2000). Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 21, 514-550.
8. Chijiiwa Y, Harada N, Misawa T, Yoshinaga M, Kabemura T & Nawata H (1991). The direct contractile effect of gastrin releasing peptide on isolated gastric smooth muscle cells of the guinea pig. Life Sci 49, PL173-178.
9. Constantinides C, Lazaris AC, Haritopoulos KN, Pantazopoulos D, Chrisofos M & Giannopoulos A (2003). Immunohistochemical detection of gastrin releasing peptide in patients with prostate cancer. World J Urol 21, 183-187.
10. Cordeaux Y, Missfelder-Lobos H, Charnock-Jones DS & Smith GC (2008). Stimulation of contractions in human myometrium by serotonin is unmasked by smooth muscle relaxants. Reprod Sci 15, 727-734.
11. Cordeaux Y, Pasupathy D, Bacon J, Charnock-Jones DS & Smith GC (2009). Characterization of serotonin receptors in pregnant human myometrium. J Pharmacol Exp Ther 328, 682-691.
12. Cordeaux Y, Tattersall M, Charnock-Jones DS & Smith GC (2010). Effects of medroxyprogesterone acetate on gene expression in myometrial explants from pregnant women. J Clin Endocrinol Metab 95, E437-447.
13. Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A & Minna JD (1985). Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 316, 823-826.
14. da Fonseca EB, Bittar RE, Carvalho MH & Zugaib M (2003). Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 188, 419-424.
15. Fonseca EB, Celik E, Parra M, Singh M & Nicolaides KH (2007). Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 357, 462-469.
16. Gardner MO, Goldenberg RL, Cliver SP, Tucker JM, Nelson KG & Copper RL (1995). The origin and outcome of preterm twin pregnancies. Obstet Gynecol 85, 553-557.
17. Goldenberg RL & Culhane JF (2003). Infection as a cause of preterm birth. Clin Perinatol 30, 677-700.
18. Gullam JE, Blanks AM, Thornton S & Shmygol A (2009). Phase-plot analysis of the oxytocin effect on human myometrial contractility. Eur J Obstet Gynecol Reprod Biol 144(Suppl 1), S20-24.
19. Ingber, DE (2006). Cellular mechanotransduction: putting all the pieces together again. FASEB J 20, 811-827.
20. Keirse MJ (1995). New perspectives for the effective treatment of preterm labor. Am J Obstet Gynecol 173, 618-628.
21. Kris RM, Hazan R, Villines J, Moody TW & Schlessinger J (1987). Identification of the bombesin receptor on murine and human cells by cross-linking experiments. J Biol Chem 262, 11215-11220.
22. Kusui T, Benya RV, Battey JF & Jensen RT (1994). Glycosylation of bombesin receptors: characterization, effect on binding, and G-protein coupling. Biochemistry 33, 12968-12980.
23. Mangham LJ, Petrou S, Doyle LW, Draper ES & Marlow N (2009). The cost of preterm birth throughout childhood in England and Wales. Pediatrics 123, e312-327.
24. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH et al (2003). Prevention of recurrent preterm delivery by 17α-hydroxyprogesterone caproate. N Engl J Med 348, 2379-2385.
25. Newman RB, Iams JD, Das A, Goldenberg RL, Meis P, Moawad A et al (2006). A prospective masked observational study of uterine contraction frequency in twins. Am J Obstet Gynecol 195, 1564-1570.
26. Norman JE, Mackenzie F, Owen P, Mactier H, Hanretty K, Cooper S et al (2009). Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet 373, 2034-2040.
27. 2α receptor in the rat myometrium during pregnancy and labor. Am J Obstet Gynecol 182, 919-925.
28. Patel O, Shulkes A & Baldwin GS (2006). Gastrin-releasing peptide and cancer. Biochim Biophys Acta 1766, 23-41.
29. Pogrzeba B, Mandrek K, Ludtke FE, Lepsien G & Golenhofen K (1991). Contractile action of gastrin-releasing peptide on isolated preparations of human gastroduodenal muscle. Dig Dis 9, 354-359.
30. Ravn V, Rasmussen BB, Hojholt L, Barfoed M, Heiberg I & Thorpe SM (1993). Reproducibility of subjective immunohistochemical estrogen- and progesterone receptor determination in human endometrium. Pathol Res Pract 189, 1015-1022.
31. Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, Thom EA, Spong CY et al (2007). A trial of 17α-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med 357, 454-461.
32. Rush RW, Keirse MJ, Howat P, Baum JD, Anderson AB & Turnbull AC (1976). Contribution of preterm delivery to perinatal mortality. Br Med J 2, 965-968.
33. Scott N, Millward E, Cartwright EJ, Preston SR & Coletta PL (2004). Gastrin releasing peptide and gastrin releasing peptide receptor expression in gastrointestinal carcinoid tumours. J Clin Pathol 57, 189-192.
34. Sessa F, Bonato M, Frigerio B, Capella C, Solcia E, Prat M et al (1990). Ductal cancers of the pancreas frequently express markers of gastrointestinal epithelial cells. Gastroenterology 98, 1655-1665.
35. Severi C, Jensen RT, Erspamer V, D'Arpino L, Coy DH, Torsoli A & Delle Fave G (1991). Different receptors mediate the action of bombesin-related peptides on gastric smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 260, G683-690.
36. Shynlova O, Mitchell JA, Tsampalieros A, Langille BL & Lye SJ (2004). Progesterone and gravidity differentially regulate expression of extracellular matrix components in the pregnant rat myometrium. Biol Reprod 70, 986-992.
37. Sooranna SR, Lee Y, Kim LU, Mohan AR, Bennett PR & Johnson MR (2004). Mechanical stretch activates type 2 cyclooxygenase via activator protein-1 transcription factor in human myometrial cells. Molecular Human Reproduction 10, 109-113.
38. Vadokas B, Ludtke FE, Lepsien G, Golenhofen K & Mandrek K (1997). Effects of gastrin-releasing peptide (GRP) on the mechanical activity of the human ileocaecal region in vitro. Neurogastroenterol Motil 9, 265-270.
39. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A & Speleman F (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3, RESEARCH0034.
40. Vangsted AJ, Andersen EV, Nedergaard L & Zeuthen J (1991). Gastrin releasing peptide GRP(14-27) in human breast cancer cells and in small cell lung cancer. Breast Cancer Res Treat 19, 119-128.
41. Vangsted AJ & Schwartz TW (1990). Production of gastrin-releasing peptide-(18-27) and a stable fragment of its precursor in small cell lung carcinoma cells. J Clin Endocrinol Metab 70, 1586-1593.
42. Williams BY & Schonbrunn A (1994). Bombesin receptors in a human duodenal tumor cell line: binding properties and function. Cancer Res 54, 818-824.
43. Young RC & Zhang P (2004). Tissue-level bioelectrical signals as the trigger for uterine contractions in human pregnancy. J Soc Gynecol Investig 11, 478-482.